Similar articles

• [Bronchopulmonary dysplasia--a one-year material].

  Farstad T, Bratlid D. Farstad T, et al. Tidsskr Nor Laegeforen. 1990 Aug 20;110(19):2524-7. Tidsskr Nor Laegeforen. 1990. PMID: 2219011 Norwegian.
• Measuring respiratory outcome.

  Greenough A. Greenough A. Semin Neonatol. 2000 May;5(2):119-26. doi: 10.1053/siny.1999.0006. Semin Neonatol. 2000. PMID: 10859706 Review.
• Predicting bronchopulmonary dysplasia.

  Schroeder P, Gortner L. Schroeder P, et al. Intensive Care Med. 1999 Feb;25(2):241-2. doi: 10.1007/pl00003766. Intensive Care Med. 1999. PMID: 10193562 No abstract available.
• Pulmonary inflammation in the pathogenesis of bronchopulmonary dysplasia.

  Groneck P, Speer CP. Groneck P, et al. Pediatr Pulmonol Suppl. 1997;16:29-30. doi: 10.1002/ppul.1950230816. Pediatr Pulmonol Suppl. 1997. PMID: 9443185 Review. No abstract available.
• Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.

  Farhath S, He Z, Nakhla T, Saslow J, Soundar S, Camacho J, Stahl G, Shaffer S, Mehta DI, Aghai ZH. Farhath S, et al. Pediatrics. 2008 Feb;121(2):e253-9. doi: 10.1542/peds.2007-0056. Pediatrics. 2008. PMID: 18245400